Stoke Therapeutics Eulerpool News

Stoke Therapeutics Stock News

Stoke Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Stoke Therapeutics news here.

• December 2 ·

  Yahoo
  Stoke Therapeutics Announces Plans to Present New Data that Support Zorevunersen as Potentially the First Disease-Modifying Medicine for Dravet Syndrome at the American Epilepsy Society 2024 Annual Meeting
• November 26 ·

  Yahoo
  An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond
• November 20 ·

  Yahoo
  Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
• November 8 ·

  Yahoo
  Wall Street Analysts Believe Stoke Therapeutics (STOK) Could Rally 66.84%: Here's is How to Trade
• November 6 ·

  Yahoo
  Need To Know: Analysts Are Much More Bullish On Stoke Therapeutics, Inc. (NASDAQ:STOK) Revenues
• November 1 ·

  Yahoo
  Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
• October 13 ·

  Yahoo
  Stoke Therapeutics assumed with an Outperform at Leerink
• October 12 ·

  Yahoo
  Stoke Therapeutics, Inc (STOK): Pioneering RNA Medicine for Genetic Diseases
• October 11 ·

  TipRanks
  Factors Influencing a ‘Buy’ Rating in Analyst Reports
• October 11 ·

  Thefly.com
  Stoke Therapeutics assumed with an Outperform at Leerink